Compatibilidad pasada de pruebas, presente, y futuro

Geoge Garratty

2003, Número 3

<< Anterior Siguiente >>

Gac Med Mex 2003; 139 (3)

Compatibilidad pasada de pruebas, presente, y futuro

Garratty G

Texto completo

Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 3-4
Archivo PDF: 27.59 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

Oberman HA. The crossmatch. A brief historical perspective. Transfusion 1981;21:645-651.
2. Beck ML, Tilzer LL. Red cell compatibility testing: a perspective for the future. Transfus Med Rev 1996;10:118-130.
3. Giblett ER. Blood group alloantibodies: an assessment of some laboratory practices. Transfusion 1977;17:299-308.
4. Garratty G. The role of compatibility tests. Transfusion 1982;22:169-172.
5. Friedman BA, Oberman HA, Chadwick AR, et al. The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion 1976;16:380-387.
6. Mintz PD, Nordine RB, Henry JB, et al. Expected hemotherapy in elective surgery. N Y State J Med 1976;76:16:380-387.
7. Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137-141.
8. Oberman HA. Abbreviation or elimination of the crossmatch. Clin Lab Med 1982;2:181-192.
9. Mintz PD, Haines AL, Sullivan ME. Incompatible crossmatch following nonreactive antibody detection test. Transfusion 1982;22:107-110.
Shulman IA, Nelson JM, Saxena S, et al. Experience with the routine use of an abbreviated crossmatch. Am J Clin Pathol 1984;82:178-181.
Lown JAG, Barr AL, Jackson JM. A reappraisal of pretransfusion testing procedures in a hospital blood bank. Pathology 1985;17:489-492.
Judd WJ. Commentary: testing for unexpected red cell antibodies-two or three reagent red cell samples? Immunohematology 1997;13:90-93.
Garratty G. How concerned should we be about missing antibodies to low incidence antigens? Transfusion 2003;43:7:844-847.
Shulman IA. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch. Arch Pathol Lab Med 1990;114:412-414.
Judd W. Requirements for the electronic crossmatch. Vox Sang 1998;74(Suppl 2):409-417.
Chapman JF, Milkins C, Voak D. The computer crossmatch: a safe alternative to the serological crossmatch. Transfus Med 2000;10:251-256.
Engelfriet Cp, Reesink HW. The use of the computer cross-match. Vox Sang 2001;80:184-192.
Growe GH, Galenza J, Mah H, et al. The implementation and use of automated group and screen procedures in a hospital transfusion laboratory. Transfus Med Rev 1996;X:144-151.
Sandler SG, Langeberg A, Rumsey DH, et al. A solid phase microtiter plate hemagglutinaiton method for pretransfusion compatibility testing. Haematologia 2000;30:149-157.
Garratty G, Telen MJ, Petz LD. Red cell antigens as functional molecules and obstacles to transfusion. Hematology (Am Soc Hematol Educ Program). 2002;1;445-462.
Garratty G. Stealth erythrocytes - a possible transfusion product for the new century? Vox Sang 2000;78(Suppl 2):143-147.